Oncolytics Biotech Inc. Files May 2025 6-K Report
Ticker: ONCY · Form: 6-K · Filed: May 8, 2025 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, routine-update
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH INC. (ONCY) filed their May 6-K, confirming foreign private issuer status and 20-F annual report filing.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on May 8, 2025, reporting for the month of May 2025. The company is a foreign private issuer based in Calgary, Alberta, Canada, and is subject to SEC Act of 1934. They are filing under SEC file number 001-38512 and will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Oncolytics Biotech Inc.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Registrant
- 001-38512 (other) — SEC File Number
- 20250508 (date) — Filing Date
- May 2025 (date) — Reporting Period
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report for the month of May 2025 and to confirm Oncolytics Biotech Inc.'s status as a foreign private issuer.
What is the SEC file number for Oncolytics Biotech Inc.?
The SEC file number for Oncolytics Biotech Inc. is 001-38512.
Which form will Oncolytics Biotech Inc. use to file its annual reports?
Oncolytics Biotech Inc. will file its annual reports under cover of Form 20-F.
Where is Oncolytics Biotech Inc. located?
Oncolytics Biotech Inc. is located in Calgary, Alberta, Canada.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 8, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 8, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).